Avian Cholera (Pasteurella multocida): Etiology, Epidemiology, Clinical Signs, Pathology, Diagnostics, Treatment, and Control in Poultry and Wild Birds

Introduction

Avian cholera, also known as fowl cholera, is a highly contagious and frequently fatal bacterial disease affecting a wide range of domestic poultry and wild bird species [1]. The disease is caused by the bacterium Pasteurella multocida, a Gram-negative, non-motile, facultatively anaerobic coccobacillus [2]. Avian cholera represents a significant economic burden on the poultry industry and poses a substantial conservation threat to vulnerable wild bird populations, including seabird colonies in remote regions [3, 4]. The term "fowl cholera meaning in bengali" translates to "মুরগির কলেরা" (murgir kolera), reflecting its historical recognition as a devastating disease in poultry. The question "fowl cholera is caused by which bacteria" is definitively answered by Pasteurella multocida, a pathogen with a complex epidemiology and variable host susceptibility [5].

Etiology

Pasteurella multocida is the etiologic agent of avian cholera [1]. The bacterium is classified into multiple serogroups (A, B, D, E, F) based on capsular antigens and into 16 somatic serotypes (1-16) based on lipopolysaccharide antigens [5]. In avian species, serogroup A is the most commonly isolated, with serotypes 1, 3, and 4 being frequently associated with outbreaks in both poultry and wild birds [5, 6]. The pathogenicity of P. multocida is mediated by several virulence factors, including a polysaccharide capsule that inhibits phagocytosis, lipopolysaccharide that induces endotoxic shock, and outer membrane proteins involved in adhesion to host cells [1]. Fimbriae and a sialidase enzyme also contribute to colonization of the respiratory mucosa [2]. The bacterium is susceptible to desiccation and direct sunlight but can survive for extended periods in moist environments, such as water and soil, which serve as potential environmental reservoirs [7].

Epidemiology

Avian cholera occurs worldwide and affects a broad host range, including chickens, turkeys, ducks, geese, and numerous wild bird species [1, 5]. The disease is particularly devastating in waterfowl and seabirds, where large-scale epornitics have been documented [8, 9, 10, 4, 11, 12, 13, 14]. The epidemiology of avian cholera is complex and influenced by host density, environmental conditions, and pathogen strain characteristics [15, 16].

Transmission

Transmission occurs primarily through the respiratory and oral routes [1]. Infected birds shed P. multocida in nasal exudates, feces, and saliva, contaminating the environment, feed, and water sources [2]. Scavenging on infected carcasses is a major mechanism for transmission in wild bird populations, particularly among gulls and other opportunistic feeders [9]. The bacterium can also be transmitted via fomites, including contaminated equipment, footwear, and vehicles [1]. Carrier birds, which harbor the organism in their nasal sinuses without showing clinical signs, play a critical role in the introduction and maintenance of the pathogen in a flock or colony [17].

Host Susceptibility and Risk Factors

Susceptibility to avian cholera varies significantly among species and even among populations within a species [18, 14]. Turkeys are generally more susceptible than chickens, and waterfowl such as eiders and snow geese are highly vulnerable [4, 17]. Stress factors, including overcrowding, poor nutrition, concurrent infections, and adverse weather conditions, increase the risk of outbreaks [19, 20]. In wild birds, colony size, vegetation cover, and the degree of host crowding in shared wetlands have been identified as significant risk factors for outbreak occurrence [15]. Herd immunity, acquired through prior exposure and the development of circulating antibodies, is a key driver of epidemic fadeout in wild populations [8].

Geographic Distribution and Impact

Avian cholera has been documented on every continent except Australia [1]. Major outbreaks have been reported in North America, Europe, Africa, and Antarctica [21, 3, 10, 12, 22, 5]. In the Canadian Arctic, recurrent outbreaks have threatened the viability of common eider (Somateria mollissima) colonies, with mortality rates reaching 43% of the local breeding population [15, 4]. On Amsterdam Island in the southern Indian Ocean, avian cholera has caused dramatic declines in endangered seabird species, including the Amsterdam albatross (Diomedea amsterdamensis) and the Indian yellow-nosed albatross (Thalassarche carteri) [3, 23]. In Antarctica, mass mortality events at penguin mega-colonies have been attributed to avian cholera, complicating surveillance for highly pathogenic avian influenza [21]. The question of "avian cholera transmission to humans" is important: P. multocida is a zoonotic pathogen capable of causing localized infections in humans following bites or scratches from infected animals, but human-to-human transmission is not a feature of this disease, and the primary concern remains within animal populations.

Clinical Signs

The clinical presentation of avian cholera is highly variable and depends on the virulence of the P. multocida strain, the host species, and the route of exposure [1]. The disease can manifest in peracute, acute, and chronic forms.

Peracute Form

The peracute form is characterized by sudden death in apparently healthy birds, often without any premonitory signs [19, 11]. Mortality can be extremely high, with losses occurring within hours of the first observed illness. This form is common in highly susceptible species, such as turkeys and waterfowl, during the initial stages of an outbreak [4].

Acute Form

The acute form is the most commonly recognized presentation [1]. Clinical signs include:

• Fever and depression.
• Anorexia and rapid weight loss.
• Mucoid to purulent discharge from the nares and mouth.
• Dyspnea and respiratory distress.
• Cyanosis of the comb and wattles.
• Diarrhea, which may be greenish or bloody.
• Swelling of the wattles, sinuses, and periocular tissues.
• Decreased egg production in laying flocks.

The clinical progression is rapid, with death typically occurring within 24 to 48 hours of the onset of signs [19].

Chronic Form

The chronic form is less common and typically follows an acute outbreak or occurs in birds with partial immunity [1]. Clinical signs are localized and include:

• Swollen joints (arthritis) and footpads.
• Torticollis (wry neck) due to infection of the inner ear or meninges.
• Chronic respiratory signs, including sinusitis and rales.
• Conjunctivitis and ocular discharge.
• Localized abscesses in the wattles and subcutaneous tissues.

Pathology

Gross and microscopic lesions in avian cholera are characteristic but not pathognomonic [24, 1].

Gross Lesions

In peracute cases, gross lesions may be absent or minimal [24]. In acute cases, the most consistent findings include:

• Petechial and ecchymotic hemorrhages on the epicardium, serosal membranes, and abdominal fat.
• Congestion and edema of the lungs.
• Enlarged, friable, and congested liver, often with multiple small, pale foci of necrosis.
• Splenomegaly with a mottled appearance.
• Catarrhal to hemorrhagic enteritis.
• Accumulation of fibrinous exudate in the pericardial sac and air sacs.

In chronic cases, lesions are localized and include fibrinous to caseous arthritis, tenosynovitis, and abscessation of the wattles and sinuses [1].

Microscopic Lesions

Histopathological examination reveals acute bacterial septicemia [24]. Key findings include:

• Fibrinous thrombi in small blood vessels.
• Focal hepatic necrosis with infiltration of heterophils.
• Splenic lymphoid depletion and necrosis.
• Interstitial pneumonia with congestion and edema.
• Fibrinous pericarditis and epicarditis.

Diagnostics

A definitive diagnosis of avian cholera requires the isolation and identification of P. multocida from affected birds [1]. A combination of clinical signs, gross pathology, and laboratory testing is used for confirmation.

Sample Collection

Samples for bacterial culture should be collected aseptically from fresh carcasses or live birds with clinical signs [1]. Preferred tissues include bone marrow, liver, spleen, lung, and heart blood. Swabs of the nasal cavity, sinuses, and wattles are also suitable.

Bacterial Culture and Identification

P. multocida grows readily on standard bacteriological media, such as blood agar and MacConkey agar, under aerobic conditions at 37 degrees Celsius [1]. Colonies are typically small, gray, and mucoid. The bacterium is identified based on Gram stain morphology (Gram-negative coccobacilli), a positive catalase and oxidase reaction, and the production of indole. Biochemical profiling using commercial identification systems can confirm the species.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting specific genes, such as the KMT1 gene, provide rapid and sensitive detection of P. multocida directly from clinical samples [3]. PCR is particularly useful for detecting the pathogen in carrier birds and environmental samples. Genotyping methods, including multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE), are used for epidemiological investigations to trace the source of outbreaks and identify strain relatedness [3, 5].

Serological Assays

Serological tests, such as enzyme-linked immunosorbent assays (ELISAs), can detect antibodies against P. multocida in serum samples [8, 23]. These assays are valuable for monitoring herd immunity in wild bird populations and for evaluating vaccine efficacy [23]. However, serology is not useful for diagnosing acute infections, as antibodies develop after the acute phase of the disease.

Differential Diagnosis

Avian cholera must be differentiated from other causes of acute septicemia and sudden death in birds [1]. Key differentials include:

• Highly pathogenic avian influenza (HPAI).
• Newcastle disease (velogenic viscerotropic form).
• Avian colibacillosis.
• Salmonellosis.
• Erysipelas.
• Duck viral enteritis.

The following Mermaid diagram illustrates a diagnostic decision tree for avian cholera.

flowchart TD
    A[Sudden death or acute illness in birds], > B{Clinical signs and gross lesions suggestive of septicemia?}
    B, >|Yes| C[Collect samples aseptically: liver, spleen, bone marrow, heart blood]
    B, >|No| D[Consider other differentials]
    C, > E[Gram stain: Gram-negative coccobacilli]
    E, > F[Culture on blood agar and MacConkey agar]
    F, > G[Colony morphology: small, gray, mucoid]
    G, > H[Biochemical tests: catalase +, oxidase +, indole +]
    H, > I[Confirm as Pasteurella multocida]
    I, > J{Further characterization needed?}
    J, >|Yes| K[PCR for KMT1 gene]
    J, >|No| L[Report diagnosis]
    K, > M[Genotyping: MLST or PFGE for epidemiological tracing]
    M, > L
    D, > N[Test for HPAI, NDV, E. coli, Salmonella, Erysipelothrix]

Treatment

Treatment of avian cholera is challenging, particularly in large flocks or wild bird populations, due to the rapid course of the disease and the development of antimicrobial resistance [19].

Antimicrobial Therapy

Antimicrobial therapy is most effective when initiated early in the course of an outbreak [1]. The choice of antimicrobial should be guided by culture and susceptibility testing, as resistance is common [19]. Historically, sulfonamides, tetracyclines, and penicillins have been used. However, resistance to sulfonamides, oxytetracycline, and enrofloxacin has been reported in P. multocida isolates from canaries [19]. Amoxicillin has been used successfully to control outbreaks in some settings [19]. In poultry, water-soluble antibiotics, such as chlortetracycline or sulfadimethoxine, are often administered via drinking water for 5 to 7 days [1]. Treatment of wild birds is generally not feasible, although targeted vaccination programs have been implemented for endangered species [23].

Alternative Therapies

Research into alternative therapies, including plant extracts, has been conducted. Extracts of Solanum incanum have demonstrated antibacterial activity against P. multocida in vitro, suggesting a potential role in traditional medicine [25]. Similarly, Cuminum cyminum extract has shown antimicrobial activity against avian cholera in chicken embryo models [26]. These approaches remain experimental and are not substitutes for conventional veterinary care.

Control and Prevention

Control of avian cholera relies on a combination of biosecurity, management practices, and vaccination [1].

Biosecurity

Strict biosecurity measures are essential to prevent the introduction and spread of P. multocida [1]. Key measures include:

• Isolation of new birds and quarantine before introduction to the flock.
• Restriction of access to poultry houses and wild bird habitats.
• Disinfection of equipment, footwear, and vehicles.
• Control of rodents, wild birds, and other potential vectors.
• Proper disposal of carcasses and waste.

Management Practices

Management practices that reduce stress and improve overall flock health can decrease susceptibility to avian cholera [1]. These include:

• Providing adequate ventilation, nutrition, and clean water.
• Avoiding overcrowding.
• Implementing all-in/all-out production systems.
• Prompt removal and disposal of sick and dead birds.

Vaccination

Vaccination is a key tool for controlling avian cholera in both domestic and wild bird populations [23, 27]. Both inactivated (killed) and live attenuated vaccines are available [1].

• Inactivated vaccines: These are typically bacterins containing multiple serotypes of P. multocida. They are administered by injection and require an adjuvant, such as aluminum hydroxide gel or propolis, to enhance the immune response [27]. Inactivated vaccines provide protection for several months but may not prevent infection in all individuals.
• Live attenuated vaccines: These vaccines are derived from avirulent strains of P. multocida and are administered via drinking water or by wing-web inoculation. They induce a strong cellular and humoral immune response but carry a risk of reversion to virulence.

For endangered wild bird species, such as the Amsterdam albatross, a specifically tailored killed vaccine has been shown to significantly reduce mortality in chicks, increasing fledging probability from 14% to 46% [23]. This approach demonstrates the potential of vaccination as a conservation tool.

Eradication and Surveillance

In domestic poultry, eradication of the pathogen from an infected flock is difficult. Depopulation of affected flocks, followed by thorough cleaning and disinfection, is often necessary to eliminate the infection [1]. Surveillance programs, including regular bacteriological monitoring of carrier birds and environmental samples, are critical for early detection and control [15, 17]. In wild bird populations, community-based participatory surveillance has proven effective for delineating outbreak patterns and predicting transmission risk [15].

Conclusion

Avian cholera, caused by Pasteurella multocida, remains a significant threat to both domestic poultry and wild bird populations worldwide. The disease is characterized by high morbidity and mortality, with clinical signs ranging from sudden death to chronic localized infections. Diagnosis relies on bacterial culture and molecular techniques, while treatment is complicated by antimicrobial resistance. Effective control requires a comprehensive approach that includes strict biosecurity, stress reduction, and strategic vaccination. Ongoing research into the epidemiology, pathogenesis, and host-pathogen interactions of P. multocida is essential for developing improved control strategies and mitigating the impact of this devastating disease on avian health and biodiversity.

References

[1] Samuel, M. D., Botzler, R. G., Wobeser, G. Chapter 12. Avian Cholera. Journal. 2008.

[2] Botzler, R. EPIZOOTIOLOGY OF AVIAN CHOLERA IN WILDFOWL. Journal of Wildlife Diseases. 1991.

[3] Jaeger, A., Lebarbenchon, C., Bourret, V., et al. Avian cholera outbreaks threaten seabird species on Amsterdam Island. PLoS ONE. 2018.

[4] Descamps, S., Jenouvrier, S., et al. Avian Cholera, a Threat to the Viability of an Arctic Seabird Colony? PLoS ONE. 2012.

[5] Pedersen, K., Dietz, H., Jørgensen, J. C., et al. PASTEURELLA MULTOCIDA FROM OUTBREAKS OF AVIAN CHOLERA IN WILD AND CAPTIVE BIRDS IN DENMARK. Journal of Wildlife Diseases. 2003.

[6] Jonas, M., Morishita, T., Angrick, E., et al. Characterization of nine Pasteurella multocida isolates from avian cholera outbreaks in Indonesia. Avian Diseases. 2001.

[7] Backstrand, J., Botzler, R. Survival of Pasteurella multocida in Soil and Water in an Area Where Avian Cholera is Enzootic. Journal of Wildlife Diseases. 1986.

[8] van Dijk, J. G. B., Iverson, S., Gilchrist, H., et al. Herd immunity drives the epidemic fadeout of avian cholera in Arctic-nesting seabirds. Scientific Reports. 2021.

[9] Wille, M., McBurney, S., Robertson, G., et al. A PELAGIC OUTBREAK OF AVIAN CHOLERA IN NORTH AMERICAN GULLS: SCAVENGING AS A PRIMARY MECHANISM FOR TRANSMISSION? Journal of Wildlife Diseases. 2016.

[10] Bodenstein, B., Beckmen, K., Sheffield, G., et al. Avian Cholera Causes Marine Bird Mortality in the Bering Sea of Alaska. Journal of Wildlife Diseases. 2015.

[11] Zinkl, J., Dey, N., Hyland, J., et al. AN EPORNITIC OF AVIAN CHOLERA IN WATERFOWL AND COMMON CROWS IN PHELPS COUNTY, NEBRASKA, IN THE SPRING, 1975. Journal of Wildlife Diseases. 1977.

[12] Leotta, G., Chinen, I., Vigo, G., et al. OUTBREAKS OF AVIAN CHOLERA IN HOPE BAY, ANTARCTICA. Journal of Wildlife Diseases. 2006.

[13] Rosen, M. N. THE 1970-71 AVIAN CHOLERA EPORNITIC'S IMPACT ON CERTAIN SPECIES. Journal of Wildlife Diseases. 1972.

[14] Blanchong, J., Samuel, M. D., Mack, G. MULTI-SPECIES PATTERNS OF AVIAN CHOLERA MORTALITY IN NEBRASKA'S RAINWATER BASIN. Journal of Wildlife Diseases. 2006. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[15] Iverson, S., Forbes, M., Simard, M., et al. Avian Cholera emergence in Arctic-nesting northern Common Eiders: using community-based, participatory surveillance to delineate disease outbreak patterns and predict transmission risk. Journal. 2016.

[16] Iverson, S. A., Gilchrist, H. G., Soos, C., et al. Injecting epidemiology into population viability analysis: avian cholera transmission dynamics at an arctic seabird colony. Journal of Animal Ecology. 2016.

[17] Samuel, M. D., Shadduck, D. J., Goldberg, D., et al. AVIAN CHOLERA IN WATERFOWL: THE ROLE OF LESSER SNOW AND ROSS'S GEESE AS DISEASE CARRIERS IN THE PLAYA LAKES REGION. Journal of Wildlife Diseases. 2005.

[18] Wray, A. K., Bell, D., Dramer, P., et al. Waterbird Susceptibility to Avian Cholera at Hayward Marsh, California, USA. Journal of Wildlife Diseases. 2016.

[19] Marietto-Gonçalves, G. A., Tonin, A. A. AVIAN CHOLERA IN CANARIES (SERINUS CANARIA): REVIEW OF 2 OUTBREAKS. Journal of Exotic Pet Medicine. 2018.

[20] Buttler, E. I., Gilchrist, H. G., Descamps, S., et al. Handling Stress of Female Common Eiders During Avian Cholera Outbreaks. Journal. 2011.

[21] Iervolino, M., Günther, A., Schuele, L., et al. Mass mortality at penguin mega-colonies due to avian cholera confounds H5N1 HPAIV surveillance in Antarctica. bioRxiv. 2025.

[22] Waller, L., Underhill, L. Management of avian cholera Pasteurella multocida outbreaks on Dyer Island, South Africa, 2002-2005. Journal. 2007.

[23] Bourret, V., Gamble, A., Tornos, J., et al. Vaccination protects endangered albatross chicks against avian cholera. Journal. 2018.

[24] Hunter, B., Wobeser, G. Pathology of experimental avian cholera in mallard ducks. Avian Diseases. 1980.

[25] Séré, M., Konaté, K., Santara, B., et al. Study of the antibacterial capacity of extracts of Solanum incanum L., (Solanaceae) traditionally used for the management of avian cholera in rural areas of Burkina Faso. World Journal of Advanced Research and Reviews. 2022.

[26] Al-Harbi, F. K. Antimicrobial activity of Cuminumcyminum extract against avian cholera in chicken embryo. International Journal of Research in Pharmaceutical Sciences. 2019.

[27] Tanlin, T. Comparison Experiment of Immune Effect between Avian Cholera Propolis Adjuvant Inactivated Vaccine and Aluminum Hydroxide Gel Inactivated Vaccine. Journal. 2012.

[28] Tjørnløv, R. S., Humaidan, J., Frederiksen, M. Impacts of avian cholera on survival of Common Eiders Somateria mollissima in a Danish colony. Journal. 2013.

[29] Pazhanivel, N., Sridhar, R., Balachandran, C., et al. Avian Cholera in an Egret (Casmerodius Albus). Journal. 2014.

[30] Descamps, S., Forbes, M., Gilchrist, H., et al. Avian cholera, post-hatching survival and selection on hatch characteristics in a long-lived bird, the common eider Somateria mollisima. Journal. 2011.

[31] Korschgen, C., Gibbs, H. C., Mendall, H. L. AVIAN CHOLERA IN EIDER DUCKS IN MAINE. Journal. 1978.

[32] Korschgen, C., Gibbs, H. C., Mendall, H. L. Avian cholera in eider ducks in Maine. Journal of Wildlife Diseases. 1978.

[33] Leotta, G., Rivas, M., Chinen, I., et al. Avian Cholera in a Southern Giant Petrel (Macronectes giganteus) from Antarctica. Journal of Wildlife Diseases. 2003.

[34] Samuel, M. D., Shadduck, D. J., Goldberg, D. ARE WETLANDS THE RESERVOIR FOR AVIAN CHOLERA? Journal of Wildlife Diseases. 2004.

[35] Smith, B. J., Higgins, K. F. Avian cholera and temporal changes in wetland numbers and densities in Nebraska's rainwater basin area. Wetlands. 1990.